Faster global financial news!
Exelixis (EXEL) stock dropped after FDA delayed potential approval of its new colon cancer treatment by three months
Exelixis (EXEL) stock dropped out of a buy zone Friday after the Food and Drug Administration delayed the potential approval of its new colon cancer treatment by three months. The combination includes Exelixis' zanzalintinib and Roche's (RHHBY) Tecentriq. William Blair analyst Andy Hsieh says it's unlikely the agency will outright reject the combo.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
AI Tokens Explained: Definition, Key Projects, and Market Outlook for Artificial Intelligence Cryptocurrencies
-
2
What is NBM Coin (NFTBlackmarket)? Status and Trading Channels Analysis
-
3
Verizon Communications Inc. (VZ) Q3 Earnings Report Earnings Per Share (EPS): $1.31, market expectation $1.27 Revenue: $34.31 billion, market expectation $34.77 billion Reporting Period: FY2026 Q3 (ended September 30, 2026) Release Date: October 26, 2026
-
4
Brent crude prices fell below $110/barrel, down over 6% from Friday's high
-
5
Which Platforms Allow Bitcoin Purchases Now? A Guide to Choosing Bitcoin Trading Apps
-
6
Virtual Currency Exchange Review: Compliance and Risk Boundaries of Major Global Platforms
-
7
What is EURe? An Analysis of the Euro Stablecoin EURe's Features, Uses, and Trading Channels
-
8
Israel will hold general elections on Tuesday, with war, security, the economy, and coalition formation being the main issues
-
9
Will Cryptocurrencies Disappear? A Comprehensive Analysis of Their Survival Prospects and Challenges
-
10
Global Crypto Exchange Analysis: Largest Platforms and Best Application Choices
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
